Role of MeCP2 in neurological disorders: current status and future perspectives
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of MeCP2 in neurological disorders: current status and future perspectives
Authors
Keywords
-
Journal
Epigenomics
Volume 10, Issue 1, Pages 5-8
Publisher
Future Medicine Ltd
Online
2017-11-27
DOI
10.2217/epi-2017-0128
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trichostatin A decreases the levels of MeCP2 expression and phosphorylation and increases its chromatin binding affinity
- (2017) Katrina V. Good et al. Epigenetics
- Asperger syndrome and early-onset schizophrenia associated with a novel MECP2 deleterious missense variant
- (2017) Aurore Curie et al. PSYCHIATRIC GENETICS
- An RNA interference screen identifies druggable regulators of MeCP2 stability
- (2017) Laura M. Lombardi et al. Science Translational Medicine
- m 6 A in mRNA: An Ancient Mechanism for Fine-Tuning Gene Expression
- (2017) Jean-Yves Roignant et al. TRENDS IN GENETICS
- MeCP2 mutations: progress towards understanding and treating Rett syndrome
- (2017) Ruth R. Shah et al. Genome Medicine
- Rett Syndrome and the Ongoing Legacy of Close Clinical Observation
- (2016) Huda Y. Zoghbi CELL
- Enrichment of mutations in chromatin regulators in people with Rett syndrome lacking mutations in MECP2
- (2016) Samin A. Sajan et al. GENETICS IN MEDICINE
- Epigenetic Determinants of Cancer
- (2016) Stephen B. Baylin et al. Cold Spring Harbor Perspectives in Biology
- MeCP2 and the enigmatic organization of brain chromatin. Implications for depression and cocaine addiction
- (2016) Juan Ausió Clinical Epigenetics
- Disruption of DNA-methylation-dependent long gene repression in Rett syndrome
- (2015) Harrison W. Gabel et al. NATURE
- The extended AT-hook is a novel RNA binding motif
- (2015) Michael Filarsky et al. RNA Biology
- MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy
- (2015) M. Neupane et al. Cancer Discovery
- Circadian Cycle-Dependent MeCP2 and Brain Chromatin Changes
- (2015) Alexia Martínez de Paz et al. PLoS One
- MeCP2: the long trip from a chromatin protein to neurological disorders
- (2014) Juan Ausió et al. TRENDS IN MOLECULAR MEDICINE
- MeCP2 post-translational modifications: a mechanism to control its involvement in synaptic plasticity and homeostasis?
- (2014) Elisa Bellini et al. Frontiers in Cellular Neuroscience
- Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor
- (2013) Matthew J Lyst et al. NATURE NEUROSCIENCE
- Chromatin context and ncRNA highlight targets of MeCP2 in brain
- (2013) Scott S Maxwell et al. RNA Biology
- MeCP2 post-translational regulation through PEST domains: two novel hypotheses
- (2009) Anita A. Thambirajah et al. BIOESSAYS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started